Skip to main content
. 2021 Apr 26;11:8977. doi: 10.1038/s41598-021-88413-2

Figure 2.

Figure 2

Antibody responses elicited by oral administration of EBY/pYD1-HA. (a) HA-specific IgG titer in the serum. (b) Secretory mucosal IgA titer in the small intestine washes. Asterisks represent statistically significant differences compare with the PBS- and EBY100/pYD1 controls. *p ˂ 0.05, **p ˂ 0.01.